Ron Hunt: Positions, Relations and Network
Director/Board Member at Rallybio Corp., Discover Ron Hunt's known position history, network and 100 relationships. Find out about his known public assets.
Source: marketscreener.com
Inform Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Inform Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Inform Diagnostics Today - Breaking & Trending Today
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript February 28, 2024 Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $0.28, expectations were $-0.3. Fulgent Genetics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to […]
Source: yahoo.com
Fulgent Moves Beyond Covid - Los Angeles Business Journal
For El Monte-based clinical diagnostic testing company Fulgent Genetics Inc., the Covid testing surge that catapulted the company from $32 million in annual revenue to the doorstep of $1 billion in just two years has now all but ended.
Source: labusinessjournal.com
Synthetica Bio Strengthens Leadership Team with Industry Experts to Accelerate Strategic Growth
/PRNewswire/ -- Synthetica Bio, a privately held healthcare technology company developing an enterprise-grade, generative artificial intelligence (GenAI)...
Source: prnewswire.com
What To Expect From Fulgent Genetics In 2023 (NASDAQ:FLGT)
The company is continuing its Phase 1 clinical trial evaluating the efficacy of FID-007 in treating various types of cancer. See why FLGT stock is a Hold.
Source: seekingalpha.com